-Reuters
KORU Medical Systems Signs Supply Agreement For Phase III Clinical Trial For A Novel Enzyme Replacement Therapy To Treat A Rare Endocrinological Disease
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume